1α,25-dihydroxyvitamin D 3 enhances fast-myosin heavy chain expression in differentiated C2C12 myoblasts

Cell Biology International

Volumn 36, Issue 5, 2012, Pages 441-447

  Okuno, Hiroshi ^a   Kishimoto, Koshi N ^a   Hatori, Masahito ^a   Itoi, Eiji ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

C2C12; Differentiation; Myosin heavy chain; Proliferation; Skeletal muscle; Vitamin D

Indexed keywords

CALCITRIOL; MESSENGER RNA; MYOSIN HEAVY CHAIN;

ANIMAL CELL; ARTICLE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL VIABILITY; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOFLUORESCENCE TEST; MOLECULAR DYNAMICS; MOUSE; MYOBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SEQUENCE ANALYSIS; WESTERN BLOTTING;

ANIMALS; CALCITRIOL; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL SURVIVAL; MICE; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MYOBLASTS; MYOSIN HEAVY CHAINS; RNA, MESSENGER;

EID: 84862505959     PISSN: 10656995     EISSN: 10958355     Source Type: Journal    
DOI: 10.1042/CBI20100782     Document Type: Article

References (40)

1. Billeter R, Heizmann CW, Howald H, Jenny E. Analysis of myosin light and heavy chain types in single human skeletal muscle fibers. Eur JBiochem 1981;116:389-95.
2. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY et al. Effect of vitamin D on falls: a metaanalysis. JAMA, J Am Med Assoc 2004;291:1999-2006.
3. Bischoff HA, Stahelin HB, Dick W, Akos R, Knecht M, Salis C et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003;18:343-51.
4. Boland R, Norman A, Ritz EH, Asselbach W. Presence of a 1,25-dihydroxy-vitamin D3 receptor in chick skeletal muscle myoblasts. Biochem Biophys Res Commun 1985;128:305-11.
5. Buitrago CG, Ronda AC, de Boland AR, Boland R. Map Kinases P38 and Jnk are activated by the steroid hormone 1alpha,25(Oh)2-vitamin D3 in the C2C12 muscle cell line. J Cell Biochem 2006;97:698-708.
6. Colston KW, Chander SK, Mackay AG, Coombes RC. Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro. Biochem Pharmacol 1992;44:693-702.
7. Costa EM, Blau HM, Feldman D. 1,25-Dihydroxyvitamin D3 receptors and hormonal responses in cloned human skeletal muscle cells. Endocrinology 1986;119:2214-20.
8. De Boland AR, Boland RL. Non-genomic signal transduction pathway of vitamin D in muscle. Cell Signal 1994;6:717-24.
9. Drittanti L, de Boland AR, Boland R. Modulation of DNA synthesis in cultured muscle cells by 1,25-dihydroxyvitamin D-3. Biochim Biophys Acta 1989;1014:112-9.
10. Dukas L, Bischoff HA, Lindpaintner LS, Schacht E, Birkner-Binder D, Damm TN et al. Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500 Mg daily. J Am Geriatr Soc 2004;52:230-6.
11. Eastwood JB, Stamp TC, De Wardener HE, Bordier PJ, Arnaud CD. The effect of 25-hydroxy vitamin D3 in the osteomalacia of chronic renal failure. Clin Sci Mol Med 1977;52:499-508.
12. Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T et al. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology 2003;144:5138-44.
13. Gallagher JC, Fowler SE, Detter JR, Sherman SS. Combination treatment with estrogen and calcitriol in the prevention of agerelated bone loss. J Clin Endocrinol Metab 2001;86:3618-28.
14. Getzenberg RH, Light BW, Lapco PE, Konety BR, Nangia AK, Acierno JS et al. Vitamin D inhibition of prostate adenocarcinoma growth and metastasis in the dunning rat prostate model system. Urology 1997;50:999-1006.
15. Graafmans WC, Ooms ME, Hofstee HM, Bezemer PD, Bouter LM, Lips P. Falls in the elderly: a prospective study of risk factors and risk profiles. Am J Epidemiol 1996;143:1129-36.
16. Hager G, Formanek M, Gedlicka C, Thurnher D, Knerer B, Kornfehl J. 1,25(Oh)2 vitamin D3 induces elevated expression of the cell cycleregulating genes P21 and P27 in squamous carcinoma cell lines of the head and neck. Acta Otolaryngol 2001;121:103-9.
17. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The P21 Cdkinteracting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993;75:805-16.
18. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 1998;13:325-49.
19. Hershberger PA, Modzelewski RA, Shurin ZR, Rueger RM, Trump DL, Johnson CS. 1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates P21(Waf1/Cip1) in vitro and in vivo. Cancer Res 1999;59:2644-9.
20. Kumar R. The Metabolism and mechanism of action of 1,25-dihydroxyvitamin D3. Kidney Int 1986;30:793-803.
21. Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE. 1 Alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res 2000;87:214-20.
22. Minghetti PP, Norman AW. 1,25(Oh)2-vitamin D3 receptors: gene regulation and genetic circuitry. FASEB J 1988;2:3043-53.
23. Miyaura C, Abe E, Kuribayashi T, Tanaka H, Konno K, Nishii Y et al. 1 Alpha,25-dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells. Biochem Biophys Res Commun 1981;102:937-43.
24. Nakagawa K, Kawaura A, Kato S, Takeda E, Okano T. 1 alpha,25-dihydroxyvitamin D(3) is a preventive factor in the metastasis of lung cancer. Carcinogenesis 2005;26:429-40.
25. Papadimitropoulos E, Wells G, Shea B, Gillespie W, Weaver B, Zytaruk N et al. Meta-analyses of therapies for postmenopausal osteoporosis. VIII: meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr rev 2002;23:560-9.
26. Pfeifer M, Begerow B, Minne HW, Abrams C, Nachtigall D, Hansen C. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 2000;15:1113-8.
27. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM et al. P27Kip1, a Cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 1994;8:9-22.
28. Ronda AC, Buitrago C, Colicheo A, de Boland AR, Roldan E, Boland R. Activation of mapks by 1alpha,25(Oh)2-vitamin D3 and 17betaestradiol in skeletal muscle cells leads to phosphorylation of elk-1 and creb transcription factors. J Steroid Biochem Mol Biol 2007;103:462-6.
29. Sato Y, Iwamoto J, Kanoko T, Satoh K. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc Dis 2005;20:187-92.
30. Schiaffino S, Reggiani C. Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol Rev 1996;76:371-23.
31. Simboli-Campbell M, Narvaez CJ, Tenniswood M, Welsh J. 1,25-dihydroxyvitamin D3 induces morphological and biochemical markers of apoptosis in Mcf-7 breast cancer cells. J Steroid Biochem Mol Biol 1996;58:367-76.
32. Simpson RU, Thomas GA, Arnold AJ. Identification of 1,25-dihydroxyvitamin D3 receptors and activities in muscle. J Biol Chem 1985;260:8882-91.
33. Spangenburg EE, Booth FW. Molecular regulation of individual skeletal muscle fibre types. Acta Physiol Scand 2003;178:413-24.
34. Staron RS, Pette D. Correlation between myofibrillar atpase activity and myosin heavy chain composition in rabbit muscle fibers. Histochemistry 1986;86:19-23.
35. Termin A, Staron RS, Pette D. Myosin heavy chain isoforms in histochemically defined fiber types of rat muscle. Histochemistry 1989;92:453-57.
36. Toyoshima H, Hunter T. P27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to P21. Cell 1994;78:67-74.
37. Verlinden L, Verstuyf A, Convents R, Marcelis S, Van Camp M, Bouillon R. Action of 1,25(Oh)2d3 on the cell cycle genes, cyclin D1, P21 and P27 in Mcf-7 cells. Mol Cell Endocrinol 1998;142:57-65.
38. Walters MR. Newly identified actions of the vitamin D endocrine system. Endocr Rev 1992;13:719-64.
39. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 1997;16:391-6.
40. Zhang X, Jiang F, Li P, Li C, Ma Q, Nicosia SV et al. Growth Suppression of ovarian cancer xenografts in nude mice by vitamin D analogue Eb1089. Clin Cancer Res 2005;11:323-8.